Efficacy of Pregabalin in the treatment of children with refractory epilepsy
Phase 2
- Conditions
- Interactable epilepsy.Episodic and paroxysmal disorders
- Registration Number
- IRCT2012101510508N5
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
children one to eighteen years, having resistant epilepsy; referred to Mofid Children's Hospital
Exclusion criteria: children with neurodegenerative diseases
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Seizure. Timepoint: 1 and 6 months after drug starting. Method of measurement: Interview.
- Secondary Outcome Measures
Name Time Method